SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate…
SUN PHARMACEUTICAL INDUSTRIES INC recalls Lisdexamfetamine Dimesylate Capsules
- Published
- 23 Jul 2025
- Units affected
- 5,448 bottles
- Agency
- FDA
- Country
- United States
The hazard
Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 9 month long term stability station (25¿C, 60%RH).
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottles, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceuticals, Inc., Cranbury, NJ 08512, NDC 57664-051-88
- Brand / company
- SUN PHARMACEUTICAL INDUSTRIES INC
- Codes / lots
- Lot # AD42648, Exp 02/28/2026
- Distribution
- Recalled units were distributed to 17 distributors who may have further distributed the product nationwide.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 23 Jul 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.